Evidence map›Paper›PMID 25626129›Full record

ArticleEmerging infectious diseases2015

Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada.

Eli B Nix, Kylie Williams, Andrew D Cox, Frank St Michael, Sandra Romero-Steiner, Daniel S Schmidt, William G McCready, Marina Ulanova

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Invasive and Non-invasive ClinicalPathogens & immunity · 2024
    Article
  3. Review
  4. Developing a vaccine forCanada communicable disease report = Releve des maladies transmissibles au Canada · 2017
    Article
  5. Article
  6. Invasive disease due to Haemophilus influenzae type A in children in Canada's north: A priority for prevention.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Eli B Nix
Kylie Williams
Andrew D Cox
Frank St Michael
Sandra Romero-Steiner
Daniel S Schmidt
William G McCready
Marina Ulanova
NOSM University · CANational Research Council Canada · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

In the post-Haemophilus influenzae type b (Hib) vaccine era that began in the 1980's, H. influenzae type a (Hia) emerged as a prominent cause of invasive disease in North American Aboriginal populations. To test whether a lack of naturally acquired antibodies may underlie increased rates of invasive Hia disease, we compared serum bactericidal activity against Hia and Hib and IgG and IgM against capsular polysaccharide between Canadian Aboriginal and non-Aboriginal healthy and immunocompromised adults. Both healthy and immunocompromised Aboriginal adults exhibited significantly higher bactericidal antibody titers against Hia than did non-Aboriginal adults (p = 0.042 and 0.045 respectively), with no difference in functional antibody activity against Hib. IgM concentrations against Hia were higher than IgG in most study groups; the inverse was true for antibody concentrations against Hib. Our results indicate that Aboriginal adults possess substantial serum bactericidal activity against Hia that is mostly due to IgM antibodies. The presence of sustained IgM against Hia suggests recent Hia exposure.

Indexed as

AdultAgedAged, 80 and overAntibodies, BacterialAntibody SpecificityAntigens, BacterialCanadaComplement System ProteinsFemaleHaemophilus InfectionsHaemophilus influenzaeHumansImmunoglobulin GImmunoglobulin MMaleMiddle AgedAntibodies, BacterialAntigens, BacterialComplement System ProteinsImmunoglobulin GImmunoglobulin MPolysaccharides, Bacterial

Identifiers

PMID25626129
PMCPMC4313637
OpenAlexW1974139643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.